In Brief Frank Smith named president of XenoSTART preclinical business unit February 27, 2026Vol.52 No.08
Clinical Roundup NHS-Galleri MCD trial fails to meet primary endpoint of stage shift February 27, 2026Vol.52 No.08By Sara Willa Ernst
Clinical Roundup Phase I/II PYNNACLE trial evaluating rezatapopt shows proof of concept for p53 reactivation February 27, 2026Vol.52 No.08
Clinical Roundup Microplastics are discovered in prostate tumors, NYU researchers present at ASCO GU February 27, 2026Vol.52 No.08
Clinical Roundup ROSELLA phase III trial of relacorilant in platinum-resistant ovarian cancer meets OS primary endpoint February 27, 2026Vol.52 No.08
Clinical Roundup Rybrevant Faspro + immunotherapy shows strong clinical benefit for recurrent or metastatic head-and-neck cancer February 27, 2026Vol.52 No.08
Clinical Roundup Adjuvant immunotherapy + hormone therapy may counteract immune-suppression in early-stage prostate cancer, Mayo-led study finds February 27, 2026Vol.52 No.08
Clinical Roundup American Heart Association tool measures heart disease risk in testicular cancer survivors February 27, 2026Vol.52 No.08
